Charles Schwab Investment Management Inc. Purchases 365,855 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Charles Schwab Investment Management Inc. boosted its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 8.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,701,881 shares of the real estate investment trust's stock after purchasing an additional 365,855 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 1.99% of Sabra Health Care REIT worth $87,502,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD boosted its position in shares of Sabra Health Care REIT by 7.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 122,630 shares of the real estate investment trust's stock valued at $1,812,000 after acquiring an additional 8,554 shares during the period. Cetera Investment Advisers boosted its holdings in Sabra Health Care REIT by 34.1% in the 1st quarter. Cetera Investment Advisers now owns 406,675 shares of the real estate investment trust's stock valued at $6,007,000 after purchasing an additional 103,413 shares during the period. Cetera Advisors LLC boosted its holdings in Sabra Health Care REIT by 996.2% in the 1st quarter. Cetera Advisors LLC now owns 149,574 shares of the real estate investment trust's stock valued at $2,209,000 after purchasing an additional 135,929 shares during the period. Bright Futures Wealth Management LLC. purchased a new position in shares of Sabra Health Care REIT during the 1st quarter valued at $548,000. Finally, GAMMA Investing LLC increased its holdings in shares of Sabra Health Care REIT by 40.0% in the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock worth $57,000 after purchasing an additional 1,052 shares during the period. Hedge funds and other institutional investors own 99.40% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on SBRA shares. Scotiabank lifted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "sector perform" rating in a research note on Friday, October 11th. Truist Financial lifted their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Citigroup raised Sabra Health Care REIT from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $17.00 to $20.00 in a report on Friday, September 13th. Finally, Wells Fargo & Company raised shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $16.00 to $20.00 in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $18.71.

Sabra Health Care REIT Price Performance

Shares of NASDAQ SBRA traded up $0.07 during trading hours on Thursday, reaching $18.91. 1,612,606 shares of the stock traded hands, compared to its average volume of 2,044,656. The company's 50-day simple moving average is $18.63 and its two-hundred day simple moving average is $16.78. The company has a market capitalization of $4.47 billion, a P/E ratio of 46.12, a price-to-earnings-growth ratio of 2.33 and a beta of 1.25. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $20.03. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The business had revenue of $178.00 million for the quarter, compared to analysts' expectations of $177.19 million. During the same period last year, the business posted $0.34 earnings per share. Equities research analysts forecast that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.35%. The ex-dividend date is Friday, November 15th. Sabra Health Care REIT's dividend payout ratio is presently 292.69%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.